Bortezomib — Dosing in CKD & Dialysis

Bortezomib (Proteasome Inhibitor): renal dosing adjustments, dialyzability (Not quantified. The label advises giving VELCADE after the dialysis procedure in patients requiring dialysis (8.6) and found no clinically significant pharmacokinetic differences by renal impairment, including patients dosed

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.